We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A restricted ...
A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
Residual CFTR function in cystic fibrosis was associated with better glucose tolerance and insulin secretion, with CFTR ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...
Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human islets ...
Biomea Fusion, Inc. has presented promising clinical results for icovamenib, a novel therapy aimed at restoring beta-cell function in patients with type 2 diabetes, at the ATTD 2025 Conference.
New research finds that a low-carbohydrate diet may improve beta-cell function in people with Type 2 diabetes. New research from the University of Alabama at Birmingham, published in the Journal of ...
Following a low-carb diet may potentially help patients manage disease more effectively and reduce medication use. Study: Effects of a Carbohydrate-Restricted Diet on β-Cell Response in Adults With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results